{"schema_version":"secwatch.filing_event.v1","accession":"0001000694-25-000006","form_type":"8-K","ticker":"NVAX","cik":"0001000694","company_name":"NOVAVAX INC","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.621176+00:00","generated_at":"2026-05-26T00:52:32.280947+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Novavax reports Q4 revenue $88M, net loss $81M; transitions COVID vaccine to Sanofi; guides 2025 adj revenue $300-350M","bullets":["Q4 2024 revenue $88M (vs $291M YoY); full year $682M (vs $984M). Product sales $50M vs $251M.","Net loss narrowed to $81M in Q4 (vs $178M); full year loss $187M (vs $545M). Cash $938M at Dec 31, 2024.","Transitioned Nuvaxovid commercial lead to Sanofi for 2025-2026 season. BLA target action date April 2025; $175M milestone upon approval.","Sold Czech facility to Novo Nordisk for $200M; gain of $52M, annual cost savings ~$80M.","2025 guidance: combined R&D+SG&A $475-525M; adjusted licensing/royalties/other revenue $300-350M."],"urls":{"canonical":"https://secwatch.observer/filing/0001000694-25-000006","json":"https://secwatch.observer/filing/0001000694-25-000006.json","markdown":"https://secwatch.observer/filing/0001000694-25-000006.md","text":"https://secwatch.observer/filing/0001000694-25-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000694/000100069425000006/0001000694-25-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000694/000100069425000006/nvax-20250227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T00:52:32.280947+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}